样式: 排序: IF: - GO 导出 标记为已读
-
Sex and the Risk of Atheromatous and Non-Atheromatous Cardiovascular Disease in CKD: Findings From the CKD-REIN Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-24 Anne-Laure Faucon MD PhD, Oriane Lambert MPH, Ziad A. Massy MD PhD, Tilman B. Drüeke MD, Christian Combe MD PhD, Denis Fouque MD PhD, Luc Frimat MD PhD, Christian Jacquelinet MD PhD, Maurice Laville MD PhD, Sophie Liabeuf PharmD PhD, Roberto Pecoits-Filho MD PhD, Marie Hauguel-Moreau MD MSc, Nicolas Mansencal MD PhD, Natalia Alencar de Pinho PhD, Bénédicte Stengel MD PhD, the CKD-REIN study collaborators
-
Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-19 Takashin Nakayama MD, Hidehiro Kaneko MD, Yuta Suzuki PhD, Akira Okada MD, Hiroyuki Morita MD, Katsuhito Fujiu MD, Norifumi Takeda MD, Akira Fukui MD, Takashi Yokoo MD, Norihiko Takeda MD, Hideo Yasunaga MD, Masaomi Nangaku MD, Kaori Hayashi MD.
-
The Case for Incremental Thinking About Kidney Stone Disease Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-18 Alan C. Pao
-
Frailty and Duration of Maintenance Dialysis: A Japanese Nationwide Cross-Sectional Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-12 Suguru Yamamoto MD PhD, Kakuya Niihata MD PhD, Tatsunori Toida MD PhD, Masanori Abe MD PhD, Norio Hanafusa MD PhD, Noriaki Kurira MD PhD
-
Identifying Major Barriers to Home Dialysis (The IM-HOME Study): Findings From a National Survey of Patients, Care Partners, and Providers Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-06 Yuvaram N.V. Reddy MBBS MPH, Matthew D. Kearney PhD MPH, Michaela Ward MS Ed, Robert E. Burke MD MS, Ann M. O’Hare MA MD, Peter P. Reese MD PhD, Meghan B. Lane-Fall MD MSHP, IM-HOME Advisory Board, Jennifer Jones, Frank Liu, Ashley Martin, April McGraw, Joanna Neumann, Amber Pettis, Page Salenger
-
Kidney Care in Times of Crises: A Review Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-06 Sami Alasfar MD MPH, Sahar H. Koubar MD, Samir C. Gautam MD, Bernard G. Jaar MD MPH
The global burden of kidney disease is increasing, paralleled by a rising number of natural and man-made crises. During these tumultuous times, accessing vital healthcare resources becomes challenging, posing significant risks to individuals, particularly those with kidney disease. This review delves into the impact of crises on kidney disease, with a particular focus on acute kidney injury (AKI),
-
Going From Point A to Point B: Changes in the Mobility of Older Persons With CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-06-01 Ana Jessica Alfaro, Christine K. Liu
-
In Reply to “The Use of Ultrasound in Peritoneal Dialysis Setting” Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-29 Vandana Dua Niyyar MD
-
Improving Diverse and Equitable Involvement of Patients and Caregivers in Research in CKD: Report of a Better Evidence and Translation–Chronic Kidney Disease (BEAT-CKD) Workshop Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-27 Rosanna Cazzolli, Amanda Sluiter, Samantha Bateman, Hayley Candler, Yeoungjee Cho, Tess Cooper, Jonathan C. Craig, Amanda Dominello, Emily Duncanson, Chandana Guha, Carmel M. Hawley, Erandi Hewawasam, Laura Hickey, Kathy Hill, Kirsten Howard, Martin Howell, Brooke M. Huuskes, Georgina L. Irish, Shilpanjali Jesudason, David W. Johnson, Ayano Kelly, Diana Leary, Karine Manera, Jasmin Mazis, Stephen McDonald
Patient and caregiver involvement can enhance the uptake and impact of research, but the involvement of patients and caregivers who are underserved and marginalized is often limited. A better understanding of how to make involvement in research more broadly accessible, supportive, and inclusive for patients with chronic kidney disease (CKD) and caregivers is needed. We conducted a national workshop
-
Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-23 Hanne Skou Jørgensen, Henriette de Loor, Jaak Billen, Nele Peersman, Pieter Vermeersch, Annemieke C. Heijboer, Fiona Ivison, Dirk Vanderschueren, Roger Bouillon, Maarten Naesens, Dirk Kuypers, Pieter Evenepoel
-
Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-22 Somkanya Tungsanga, Winston Fung, Ikechi G. Okpechi, Feng Ye, Anukul Ghimire, Philip Kam-Tao Li, Michael G. Shlipak, Sri Lekha Tummalapalli, Silvia Arruebo, Fergus J. Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, Adeera Levin, Syed Saad, Marcello Tonelli, Aminu K. Bello, David W. Johnson
Established therapeutic interventions effectively mitigate the risk and progression of chronic kidney disease (CKD). Countries and regions have a compelling need for organizational structures that enable early identification of people with CKD who can benefit from these proven interventions. We report the current global status of CKD detection programs. A multinational cross-sectional survey. Stakeholders
-
Intensity-Specific Physical Activity Measured by Accelerometer, Genetic Susceptibility, and the Risk of Kidney Stone Disease: Results From the UK Biobank Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-14 Yashu Liu, Po-Wen Ku, Zhenhua Li, Honghao Yang, Tingjing Zhang, Liangkai Chen, Yang Xia, Song Bai
-
Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-14 Yujie Wang, Dacheng Chen, Ruimin Hu, Yuan Zhang, Dandan Liang, Feng Xu, Feng Liu, Xiaodong Zhu, Yao Lin, Xue Yang, Xumeng Liu, Guolan Xing, Shaoshan Liang, Caihong Zeng
-
Association of Obesity With Kidney and Cardiac Outcomes Among Patients With Glomerular Disease: Findings From the Cure Glomerulonephropathy Network Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-13 Evan M. Zeitler, Dorey A. Glenn, Yichun Hu, Ronald J. Falk, Susan L. Hogan, Amy K. Mottl, CureGN Investigators, li Gharavi MD, Larry Greenbaum MD PhD, Michelle Rheault MD, William E. Smoyer MD, Lawrence B. Holzman MD, Brenda Gillespie PhD, Bruce Robinson MD MS, Laura Mariani MD, Cindy Roy PhD, Lisa Guay-Woodford MD, Afshin Parsa MD MPH
The influence of obesity on cardiorenal outcomes in individuals with glomerular disease is incompletely known. This study examined the association between obesity and kidney and cardiovascular outcomes in children and adults with glomerular kidney disease. Prospective, multicenter, observational study. Participants in the Cure Glomerulonephropathy Network (CureGN) who were≥5 years of age at enrollment
-
Time-Varying Proteinuria in Predicting Outcome of IgA Nephropathy Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-05-11 Takaya Sasaki MD PhD, Nobuo Tsuboi MD PhD
-
Referral and Beyond: Restructuring the Kidney Transplant Process to Support Greater Access in the United States Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-24 Catherine R. Butler, Peter P. Reese, Xingxing S. Cheng
Advocates for improved equity in kidney transplants in the United States have recently focused their efforts on initiatives to increase referral for transplant evaluation. However, because donor kidneys remain scarce, increased referrals are likely to result in an increasing number of patients proceeding through the evaluation process without ultimately receiving a kidney. Unfortunately, the process
-
Imprecise, Measure it Twice? Dealing With the Biological Variability of Albuminuria in Diabetes Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-23 Sophie E. Claudel, Sushrut S. Waikar
-
How Low Can You Go With Dose of Continuous Kidney Replacement Therapy? Is That the Right Question to Ask? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-20 J. Pedro Teixeira, Ashita Tolwani, Javier A. Neyra
-
Living With a Rare Glomerular Disease: A Call to Action for Early Diagnosis and Innovation in Treatment Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-20 Antonia King, Fernando Caravaca-Fontán
-
Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving! Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-20 Ashima Gulati, Marva Moxey-Mims
-
Hypertension and Proteinuria in a Pregnancy: A Quiz Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-19 Massimo Torreggiani, Maria Rita Stancanelli, Linda Njandjo, Antioco Fois, Giorgina Barbara Piccoli
-
Peritoneal Dialysis Technique Survival: A Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-17 Caroline M. Hsu, Nien Chen Li, Eduardo K. Lacson Jr., Daniel E. Weiner, Susan Paine, Karen Majchrzak, Christos Argyropoulos, Maria-Eleni Roumelioti, V. Shane Pankratz, Dana Miskulin, Harold J. Manley, Page Salenger, Doug Johnson, H. Keith Johnson, Antonia Harford
-
Association of Race and Ethnicity With High Longevity Deceased Donor Kidney Transplantation Under the US Kidney Allocation System Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-16 Nour W. Asfour, Kevin C. Zhang, Jessica Lu, Peter P. Reese, Milda Saunders, Monica Peek, Molly White, Govind Persad, William F. Parker
The US Kidney Allocation System (KAS) prioritizes candidates with a≤20% estimated posttransplant survival (EPTS) to receive high-longevity kidneys defined by a≤20% Kidney Donor Profile Index (KDPI). Use of EPTS in the KAS deprioritizes candidates with older age, diabetes, and longer dialysis durations. We assessed whether this use also disadvantages race and ethnicity minority candidates, who are younger
-
Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A New Instrument on the Horizon to Improve Risk Assessment in This High-Risk Population? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-16 Veronica T. Costa e Silva, Ogechi M. Adingwupu, Lesley A. Inker
-
Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-15 Petter Bjornstad, Gabriel Richard, Ye Ji Choi, Kristen L. Nowak, Cortney Steele, Michel B. Chonchol, Kristen J. Nadeau, Timothy Vigers, Laura Pyle, Kalie Tommerdahl, Daniel H. van Raalte, Allison Hilkin, Lynette Driscoll, Carissa Birznieks, Katharina Hopp, Wei Wang, Charles Edelstein, Robert G. Nelson, Adriana V. Gregory, Timothy L. Kline, Denis Blondin, Berenice Gitomer
-
Erythrocytosis and CKD: A Review Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-15 Mabel Aoun, Michel Jadoul, Hans-Joachim Anders
Erythrocytosis or polycythemia is defined as an increase in red blood cell concentration above the age- and sex-specific normal levels. Unlike anemia, which is very common in patients with chronic kidney disease (CKD), erythrocytosis is less frequent but requires specific understanding by health care professionals in order to provide the best care. Erythrocytosis, especially when undiagnosed and untreated
-
The Impact of Kidney Transplantation on a Breadth of Cognitive Measures Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-11 Nidhi Ghildayal, Dorry L. Segev, Mara McAdams-DeMarco
-
Reducing Infections in Outpatient Hemodialysis: The Impact of Human Factors Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-11 Jeffrey I. Silberzweig
-
Unraveling Barriers in Access to Living Donor Kidney Transplantation for South Asian Canadian Populations Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-11 Amy D. Waterman, LaShara A. Davis, Solaf Al Awadhi
-
Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-10 Kristen L. Nowak, Federica Moretti, Nicole Bussola, Cortney N. Steele, Adriana V. Gregory, Timothy L. Kline, Sumana Ramanathan, Giovanni Trapletti, Cesare Furlanello, Linda McCormick, Michel Chonchol
-
“Atypical” Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-09 Vanja Ivković MD PhD, Andreas Kronbichler MD PhD, Tiffany N. Caza MD PhD
-
In Reply to “‘Atypical’ Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?” Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-09 Bertrand Chauveau MD, Jean-Baptiste Gibier MD PhD, Marion Rabant MD PhD
-
It Is Time to Replace the Term “Patient Care Technician” in Dialysis Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-07 Laura C. Plantinga, Danilo B. Concepcion, Susan A. Chapman, Jennifer Craft Morgan, Fran Rickenbach, Clarica Douglas-Ajayi, Delphine S. Tuot, Bernard G. Jaar, Megan Urbanski
-
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-06 Daniel Edmonston, Michaela A.A. Fuchs, Emily J. Burke, Tamara Isakova, Myles Wolf, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators, Lawrence J. Appel MD MPH, Jing Chen MD MMSc MSc, Debbie L. Cohen MD, Harold I. Feldman MD MSCE, Alan S. Go MD, James P. Lash MD, Robert G. Nelson MD PhD MS, Mahboob Rahman MD, Panduranga S. Rao MD, Vallabh O. Shah PhD MS, Mark L. Unruh MD MS
-
24-Hour Urinary Chemistries and Kidney Stone Risk Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-04-05 Pietro Manuel Ferraro, Eric N. Taylor, Gary C. Curhan
Most previous studies of the relationship between urinary factors and kidney stone risk have either assumed a linear effect of urinary parameters on kidney stone risk or implemented arbitrary thresholds suggesting biologically implausible “all-or-nothing” effects. In addition, little is known about the hierarchy of effects of urinary factors on kidney stone risk. This study evaluated the independent
-
Glomerular Filtration Rate Estimation Using β2-Microglobulin and β-Trace Protein in Adults With Solid Tumors: A Prospective Cross-Sectional Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-26 Verônica T. Costa e Silva, Luiz A. Gil Jr, Lesley A. Inker, Renato A. Caires, Elerson Costalonga, George Coura-Filho, Marcelo T. Sapienza, Gilberto Castro Jr, Maria D.P. Estevez-Diz, Dirce Maria T. Zanetta, Leila Antonângelo, Lia Marçal, Hocine Tighiouart, Shiyuan Miao, Paul Mathew, Andrew S. Levey, Emmanuel A. Burdmann
-
The Dialysis Social Worker: Patients’ Best Defense to Meet Health-Related Social Needs Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-22 Megan Urbanski, Teri Browne, Laura Plantinga
-
An Incidental Finding: My Journey to Patient Advocacy Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-22 Janet Tennyson
-
Anti-Neuron–Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-22 Daisuke Honda, Issei Okunaga, Daichi Omote, Hiroko Inoue, Kaho Yamasaki, Hanae Wakabayashi, Michiko Suzuki, Masashi Aizawa, Shigeki Tomita, Jun-ichiro Ikeda, Katsuhiko Asanuma
We present the case of a 61-year-old man who developed nephrotic syndrome as a result of syphilis-associated secondary membranous nephropathy (MN). The patient showed nephrotic syndrome remission following antibiotic treatment for syphilis alone. Pathologically, the target antigen of immune complexes accumulated on glomerular basement membranes (GBM) in secondary MN caused by syphilis has been reported
-
Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-20 Mengyao Tang, Anders H. Berg, Hui Zheng, Eugene P. Rhee, Andrew S. Allegretti, Sagar U. Nigwekar, S. Ananth Karumanchi, James P. Lash, Sahir Kalim
Hemoglobin A (HbA) is widely used to estimate glycemia, yet it is less reliable in patients with chronic kidney disease (CKD). There is growing interest in the complementary use of glycated albumin (GA) to improve glycemic monitoring and risk stratification. However, whether GA associates with clinical outcomes in a non-dialysis-dependent CKD population remains unknown. Prospective cohort study. 3
-
US Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-20 Kirsten L. Johansen, David T. Gilbertson, Shuling Li, Suying Li, Jiannong Liu, Nicholas S. Roetker, Elaine Ku, Ivonne H. Schulman, Raquel C. Greer, Kevin Chan, Kevin C. Abbott, Catherine R. Butler, Ann M. O’Hare, Neil R. Powe, Yuvaram N.V. Reddy, Jon Snyder, Wendy St. Peter, Janelle S. Taylor, Eric D. Weinhandl, James B. Wetmore
-
Clinical Significance of the Cystic Phenotype in Alport Syndrome Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-19 Letizia Zeni, Federica Mescia, Diego Toso, Chiara Dordoni, Cinzia Mazza, Gianfranco Savoldi, Laura Econimo, Roberta Cortinovis, Simona Fisogni, Federico Alberici, Francesco Scolari, Claudia Izzi
-
2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-19 Nelson Leung, Samih H. Nasr
Amyloidosis is a protein folding disease that causes organ injuries and even death. In humans, 42 proteins are now known to cause amyloidosis. Some proteins become amyloidogenic as a result of a pathogenic variant as seen in hereditary amyloidoses. In acquired forms of amyloidosis, the proteins form amyloid in their wild-type state. Four types (serum amyloid A, transthyretin, apolipoprotein A-IV, and
-
Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-15 Natasha Rasaratnam, Agus Salim, Irene Blackberry, Mark E. Cooper, Dianna J. Magliano, Peter van Wijngaarden, Suresh Varadarajan, Julian W. Sacre, Jonathan E. Shaw
Evidence has demonstrated that albuminuria is a key diagnostic and prognostic marker of diabetic chronic kidney disease, but the impact of its day-to-day variability has not been adequately considered. This study quantified within-individual variability of albuminuria in people with type 2 diabetes to inform clinical albuminuria monitoring. Descriptive cross-sectional analysis. People with type 2 diabetes
-
Anti–Glomerular Basement Membrane Disease: Broadening the Spectrum Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-15 Lynn D. Cornell
-
Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-13 Keisuke Okamoto, Hidetada Fukushima, Masahiko Kawaguchi, Kazuhiko Tsuruya
-
In Reply to “EKFC Versus CKD-EPI Equation in Young Adults? No Definitive Answer” Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-13 Lesley A. Inker MD MS, Ogechi M. Adingwupu MD MPH, Andrew S. Levey MD
-
Trajectories of Physical Resilience Among Older Veterans With Stage 4 CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-12 C. Barrett Bowling, Theodore S.Z. Berkowitz, Brett T. Burrows, Jessica E. Ma, Heather E. Whitson, Battista Smith, Steven D. Crowley, Virginia Wang, Matthew L. Maciejewski, Maren K. Olsen
Although functional impairment is common among older adults with chronic kidney disease (CKD), functional reserve before an acute health event and physical resilience after the event have not been characterized in this population. The purpose of this study was to identify distinct patterns of physical function before and after an acute health event among older veterans with stage 4 CKD. Prospective
-
Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-12 Evelyn Meléndrez-Balcázar, Karla Aranda-Vela, Alberto Cervantes-Hernández, Samuel López-Cureño
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal amyloid fibrils and accumulate throughout the body. The kidney is one of the main organs affected in amyloid light chain (AL) amyloidosis and ATTRv amyloidosis. The most common clinical presentation is proteinuria, which consists
-
EKFC Versus CKD-EPI Equation in Young Adults? No Definitive Answer Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-12 Pierre Delanaye MD PhD, Hans Pottel PhD
-
Gestational Exposure to Maternal Systemic Glucocorticoids and Childhood Risk of CKD Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-11 You-Lin Tain, Lung-Chih Li, Hsiao-Ching Kuo, Chien-Ning Hsu
-
Thiazides for Nephrolithiasis Prevention: Written in Stone? Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-08 Anna L. Zisman
-
A Holistic Framework for the Evaluation of Kidney Function in a Gender-Diverse Landscape Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-06 Keila Turino Miranda, Dina N. Greene, David Collister, Matthew D. Krasowski, Sofia B. Ahmed, Lauren R. Cirrincione, Sylvia E. Rosas, Nathalie Saad, Christina C. Pierre
The most commonly used equations to estimate glomerular filtration rate incorporate a binary male-female sex coefficient, which has important implications for the care of transgender, gender-diverse, and nonbinary (TGD) people. Whether “sex assigned at birth“ or a binary “gender identity“ is most appropriate for the computation of estimated glomerular filtration rate (eGFR) is unknown. Furthermore
-
Addressing Housing Issues Among People With Kidney Disease: Importance, Challenges, and Recommendations Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-06 Tessa K. Novick, Ben King
Kidney disease disproportionately impacts people with low socioeconomic status, and low socioeconomic status is associated with worse outcomes for people with kidney disease. Unstable housing, which includes housing insecurity and homelessness, is increasing due to rising housing costs. There is mounting evidence that unstable housing and other health-related social needs are partially driving worse
-
Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-05 Marina de Cos, Gohar Mosoyan, Kinsuk Chauhan, Jonathan P. Troost, Jenny S. Wong, Sean Lefferts, Paul Morgan, Kristin Meliambro, Marc Egerman, Justina Ray, Tom Parker, Daniel Levine, Surya Seshan, Yoni Bardash, Benjamin Horowitz, Candice A. Kent, Melissa M. Shaw, Alan Perlman, Dennis G. Moledina, Steven G. Coca, Kirk N. Campbell
-
Enhancing Kidney Transplantation and the Role of Xenografts: Report of a Scientific Workshop Sponsored by the National Kidney Foundation Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-05 Andrew B. Adams, Emily A. Blumberg, John S. Gill, Eliezer Katz, Tatsuo Kawai, Jesse D. Schold, Megan Sykes, Alfred Tector, David H. Sachs
Chronic kidney disease affects an estimated 37 million people in the United States; of these,>800,000 have end-stage renal disease requiring chronic dialysis or a kidney transplant to survive. Despite efforts to increase the donor kidney supply, approximately 100,000 people are registered on the kidney transplant wait-list with no measurable decrease over the past 2 decades. The outcomes of kidney
-
Impact of Prior Abdominal Procedures on Peritoneal Dialysis Catheter Outcomes: Findings From the North American Peritoneal Dialysis Catheter Registry Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-04 Wazaira A. Khan, Matthew J. Oliver, John H. Crabtree, Alix Clarke, Sean Armstrong, Danielle Fox, Rachel Fissell, Arsh K. Jain, Sarbjit V. Jassal, Susie L. Hu, Peter Kennealey, Scott Liebman, Brendan McCormick, Bogdan Momciu, Robert P. Pauly, Beth Pellegrino, Jeffrey Perl, James L. Pirkle Jr, Troy J. Plumb, Pietro Ravani, Rebecca Seshasai, Ankur Shah, Nikhil Shah, Jenny Shen, Gurmukteshwar Singh, Karthik
-
Residential Racial and Ethnic Segregation and Post–Kidney Transplant Dementia, Allograft Loss, and Mortality Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-04 Yusi Chen MHS, Yiting Li MPH, Yi Liu ScM, Byoungjun Kim PhD, Jessica M. Ruck MD, Maya N. Clark-Cutaia PhD ACNP-BC, Aarti Mathur MD PhD, Tanjala S. Purnell PhD, Roland J. Thorpe Jr. PhD, Deidra C. Crews MD ScM, Sarah L. Szanton PhD, Dorry L. Segev MD PhD, Mara McAdams-DeMarco PhD
-
Human Factors Contributing to Infection Prevention in Outpatient Hemodialysis Centers: A Mixed Methods Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-04 Sarah Henrickson Parker, Matthew N. Jesso, Laurie D. Wolf, Kerry Avondet Leigh, Stephanie Booth, Nicole Gualandi, Renee E. Garrick, Alan S. Kliger, Priti R. Patel
Infection prevention efforts in dialysis centers can avert patient morbidity and mortality but are challenging to implement. The objective of this study was to better understand how the design of the work system might contribute to infection prevention in outpatient dialysis centers. Mixed methods, observational study. Six dialysis facilities across the United States visited by a multidisciplinary
-
Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study Am. J. Kidney Dis. (IF 9.4) Pub Date : 2024-03-01 John M. Hollingsworth, Mary K. Oerline, Ryan S. Hsi, Joseph J. Crivelli, Noah Krampe, John R. Asplin, Vahakn B. Shahinian